PMDA drug package insert
シアリス
PMDA OTC drug · エスエス製薬株式会社 · package insert Jul 31, 2026
Key facts
| Brand names | シアリス |
|---|---|
| Companies | 製造販売元／エスエス製薬株式会社 |
| Product type | OTC drug |
| OTC risk class | 要指導医薬品 |
| OTC dosage form | 錠剤 |
| OTC effect category | その他の泌尿生殖器官及び肛門用薬 |
| Package insert date | Jul 31, 2026 |
| PMDA document key | 170039_K2607000005 |
| PMDA company code | 170039 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: